Multi-cohort Investigational Study to Evaluate the Impact of Pelvic Mp-3TMRI and Whole-body 68Ga-PSMA PET/CT for Diagnosis of Clinically-significant Prostate Cancer and Pre-surgical Staging
Latest Information Update: 01 Apr 2025
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- Acronyms BIOPSTAGE
Most Recent Events
- 30 Jan 2025 Status changed from recruiting to discontinued.
- 31 May 2023 Planned End Date changed from 1 Jan 2022 to 1 Jan 2024.
- 31 May 2023 Planned primary completion date changed from 1 Jan 2022 to 1 Jan 2024.